In oncology and within the emerging field of AllergoOncology concerned with the study of IgE and Th2 immune responses in allergy and cancer [91,92], recent studies have sought to utilize the BAT to predict hypersensitivity to a therapeutic agent, such as to chemotherapeutic drugs, and biological agents, such as monoclonal antibodies. The gene discussed is IGHE; the disease is Allergy.